Marija Veljača

792 total citations
9 papers, 440 citations indexed

About

Marija Veljača is a scholar working on Genetics, Molecular Biology and Pharmacology. According to data from OpenAlex, Marija Veljača has authored 9 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Genetics, 2 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Marija Veljača's work include Inflammatory Bowel Disease (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers) and Inflammatory mediators and NSAID effects (2 papers). Marija Veljača is often cited by papers focused on Inflammatory Bowel Disease (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers) and Inflammatory mediators and NSAID effects (2 papers). Marija Veljača collaborates with scholars based in Croatia, United States and France. Marija Veljača's co-authors include Antonio Guglietta, Charles A. Lesch, K Chan, Karmen Brajša, Ivana Čepelak, Michael J. Parnham, Željko Ferenčić, Vesna Eraković Haber, Tihana Žanić‐Grubišić and Ognjen Čulić and has published in prestigious journals such as Gastroenterology, Journal of Pharmacology and Experimental Therapeutics and Life Sciences.

In The Last Decade

Marija Veljača

9 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marija Veljača Croatia	8	116	115	89	76	64	9	440
Snježana Čužić Croatia	13	85 0.7×	149 1.3×	93 1.0×	32 0.4×	107 1.7×	24	558
Marie E. Kerl United States	16	167 1.4×	101 0.9×	121 1.4×	25 0.3×	60 0.9×	38	770
Olivier Dossin France	13	168 1.4×	121 1.1×	51 0.6×	29 0.4×	116 1.8×	27	520
Maria Korzon Poland	14	158 1.4×	95 0.8×	82 0.9×	25 0.3×	180 2.8×	60	590
Masashi Uchida Japan	12	161 1.4×	87 0.8×	56 0.6×	26 0.3×	89 1.4×	63	477
Savio D’Souza United Kingdom	7	206 1.8×	112 1.0×	178 2.0×	22 0.3×	168 2.6×	11	825
Rhonda S. Fishel United States	9	146 1.3×	73 0.6×	149 1.7×	13 0.2×	85 1.3×	12	589
D N Challacombe United Kingdom	16	201 1.7×	56 0.5×	171 1.9×	48 0.6×	79 1.2×	39	791
A. Emin Kürekçi Türkiye	13	151 1.3×	33 0.3×	64 0.7×	95 1.3×	150 2.3×	30	694
J Demonty Belgium	10	86 0.7×	101 0.9×	192 2.2×	17 0.2×	92 1.4×	31	564

Countries citing papers authored by Marija Veljača

Since Specialization

Citations

This map shows the geographic impact of Marija Veljača's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marija Veljača with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marija Veljača more than expected).

Fields of papers citing papers by Marija Veljača

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marija Veljača. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marija Veljača. The network helps show where Marija Veljača may publish in the future.

Co-authorship network of co-authors of Marija Veljača

This figure shows the co-authorship network connecting the top 25 collaborators of Marija Veljača. A scholar is included among the top collaborators of Marija Veljača based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marija Veljača. Marija Veljača is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Čulić, Ognjen, Vesna Eraković Haber, Ivana Čepelak, et al.. (2002). Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects. European Journal of Pharmacology. 450(3). 277–289. 181 indexed citations

Veljača, Marija, Boris Mildner, Karmen Brajša, et al.. (2002). Safety, tolerability and pharmacokinetics of PL 14736, a novel agent for treatment of ulcerative colitis, in healthy male volunteers.. 74. 24 indexed citations

Veljača, Marija, et al.. (2001). The development of PL 14736 for treatment of inflammatory bowel disease. Inflammopharmacology. 10. 564–565. 14 indexed citations

Veljača, Marija. (2001). Anti-inflammatory peptides and proteins in inflammatory bowel disease.. PubMed. 2(10). 1387–94. 5 indexed citations

Romano, Marco, et al.. (1996). Increased gastroduodenal concentrations of transforming growth factor alpha in adaptation to aspirin in monkeys and rats. Gastroenterology. 110(5). 1448–1455. 22 indexed citations

Veljača, Marija, et al.. (1995). BPC-15 reduces trinitrobenzene sulfonic acid-induced colonic damage in rats.. Journal of Pharmacology and Experimental Therapeutics. 272(1). 417–422. 89 indexed citations

Veljača, Marija, et al.. (1995). Digestion of h-EGF, h-TGF alpha, and BPC-15 in human gastric juice. Pharmacological Research. 31. 70–70. 28 indexed citations

Veljača, Marija, et al.. (1995). Protection of BPC-15 on TNBS-induced colitis in rats: Possible mechanisms of action. Pharmacological Research. 31. 13–13. 19 indexed citations

Sikirić, Predrag, Sven Seiwerth, Željko Grabarević, et al.. (1994). The beneficial effect of BPC 157, a 15 amino acid peptide BPC fragment, on gastric and duodenal lesions induced by restraint stress, cysteamine and 96% ethanol in rats. A comparative study with H2 receptor antagonists, dopamine promotors and gut peptides. Life Sciences. 54(5). PL63–PL68. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact